Jason Hsu
Director · Immix Biopharma, Inc.
IndividualBuying only
- 2024
- May 29, 2026
- 2
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Hsu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gabriel S. Morris - $5K in IMMX purchases and sales in the last 12 months
- Ilya M. Rachman - $5K in IMMX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason Hsu?
Jason Hsu is a corporate insider, tracked as Director of Immix Biopharma, Inc. (IMMX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jason Hsu last file a Form 4?
The most recent primary Form 4 on record is dated 29 May 2026, one of 2 filings going back to 2024.
Has Jason Hsu been buying or selling stock?
Recorded transactions: 2 open-market purchases ($104K) and 0 open-market sales across all tracked filings.
